✦ LIBER ✦

A phase II study of O6-benzylguanine and temozolomide in pediatric patients with recurrent or progressive high-grade gliomas and brainstem gliomas: a Pediatric Brain Tumor Consortium study

✍ Scribed by Katherine E. Warren; Sri Gururangan; J. Russell Geyer; Roger E. McLendon; Tina Young Poussaint; Dana Wallace; Frank M. Balis; Stacey L. Berg; Roger J. Packer; Stewart Goldman; Jane E. Minturn; Ian F. Pollack; James M. Boyett; Larry E. Kun

Publisher: Springer US
Year: 2011
Tongue: English
Weight: 225 KB
Volume: 106
Category: Article
ISSN: 0167-594X
DOI: 10.1007/s11060-011-0709-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of the farnesyl transfe

A phase II study of the farnesyl transferase inhibitor, tipifarnib, in children with recurrent or progressive high-grade glioma, medulloblastoma/primitive neuroectodermal tumor, or brainstem glioma: A children's oncology group study

✍ Maryam Fouladi; H. Stacy Nicholson; Tianni Zhou; Fred Laningham; Kathleen J. Hel 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 2 views

## Abstract ## BACKGROUND. An open‐label Phase II study of tipifarnib was conducted to evaluate its safety and efficacy in children with recurrent or refractory medulloblastoma (MB)/primitive neuroectodermal tumor (PNET), high‐grade glioma (HGG), and diffuse intrinsic brainstem glioma (BSG). ## M

A phase I/II trial and pharmacokinetic s

A phase I/II trial and pharmacokinetic study of ixabepilone in adult patients with recurrent high-grade gliomas

✍ David M. Peereboom; Jeffrey G. Supko; Kathryn A. Carson; Tracy Batchelor; Surasa 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 187 KB

Phase-1 trial of gefitinib and temozolom

Phase-1 trial of gefitinib and temozolomide in patients with malignant glioma: a North American brain tumor consortium study

✍ Michael D. Prados; W. K. A. Yung; Patrick Y. Wen; Larry Junck; Timothy Cloughesy 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 325 KB

Oral topotecan in children with recurren

Oral topotecan in children with recurrent or progressive high-grade glioma : A Phase I/II study by the German Society for Pediatric Oncology and Hematology

✍ Sabine Wagner; Bernhard Erdlenbruch; Alfred Längler; Astrid Gnekow; Joachim Kühl 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB 👁 1 views

## Abstract ## BACKGROUND Continuous oral treatment with topotecan may be more effective than the typical 1‐day and 5‐day treatment schedules. In previous studies of continuous treatment with topotecan, increased intestinal side effects were reported in adult patients; however, the experience in p

Erratum to: A phase I/II trial and pharm

Erratum to: A phase I/II trial and pharmacokinetic study of ixabepilone in adult patients with recurrent high-grade gliomas

✍ David M. Peereboom; Jeffrey G. Supko; Kathryn A. Carson; Tracy Batchelor; Surasa 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 86 KB

Phase II study of oxaliplatin in childre

Phase II study of oxaliplatin in children with recurrent or refractory medulloblastoma, supratentorial primitive neuroectodermal tumors, and atypical teratoid rhabdoid tumors : A pediatric brain tumor consortium study

✍ Maryam Fouladi; Susan M. Blaney; Tina Young Poussaint; Burgess B. Freeman III; R 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 2 views